http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-1009589-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9437fd9674b0182783b7679cf8295224
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2018-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6219e820c29bbfcbec250dc4c5f0815
publicationDate 2019-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GR-1009589-B
titleOfInvention PHARMACEUTICAL MEDICAMENTS FOR THE TREATMENT OF ANEMIA, in suitable containers, kept WATERPROOF spaced THE ACTIVE INGREDIENTS: COMPLEX OF TRISTHENOUS IRON WITH N-ACETYL-L-aspartic CASEIN AND pentahydrate calcium folinate
abstract The invention relates to a pharmaceutical composition in the form of a single dose oral solution comprising as active ingredients the complex of ferric iron with N-acetyl-L-aspartic casein and calcium pentahydrate calcium folate. The trivalent iron complex with N-acetyl-L-aspartic casein is titrated with trivalent iron and complexed with casein, N-acetyl-L-aspartic acid and stored as a solution in a cylindrical vial. Calcium pentahydrate is contained in powder form in a storage space in the vial sealing cap and is kept tightly separated from the solution in the vial. The vial sealing system with storage space is suitably configured to allow the two substances to be mixed just before use for immediate intake. The resulting drug helps to treat both chronic anemia and anemia during pregnancy and lactation.
priorityDate 2018-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009035385-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006021843-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3034512-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013157974-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131709957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449635144

Total number of triples: 30.